Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (751-760 of 850) with videos related to

Pageof 85
Sort By:
International Urology and Nephrology|May 7, 2025
Oncological outcomes after non-surgical management versus radical cystectomy in non-organ-confined non-urothelial bladder cancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
BJU International|September 24, 2013
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasisNiccolo M Passoni, Harun Fajkovic, Evanguelos Xylinas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
World Journal of Urology|October 14, 2022
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penisStefano Tappero, Mattia Piccinelli, Francesco Barletta, et al.
Marine Drugs|March 24, 2022
Study of Structure-Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer AgentsMaxim E Zhidkov, Moritz Kaune, Alexey V Kantemirov, et al.
European Urology Open Science|August 18, 2025
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional CohortAlexander Giesen, Daimantas Milonas, Annouschka Laenen, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
International Journal of Cancer|February 14, 2014
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerMartina Kluth, Silvia Harasimowicz, Lia Burkhardt, et al.
International Urology and Nephrology|February 22, 2023
Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalitiesCristina Cano Garcia, Mattia Luca Piccinelli, Stefano Tappero, et al.
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
Pageof 85

Showing results (751-760 of 850) with videos related to

Sort By:
Pageof 85
International Urology and Nephrology|May 7, 2025
Oncological outcomes after non-surgical management versus radical cystectomy in non-organ-confined non-urothelial bladder cancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
BJU International|September 24, 2013
Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasisNiccolo M Passoni, Harun Fajkovic, Evanguelos Xylinas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
World Journal of Urology|October 14, 2022
Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penisStefano Tappero, Mattia Piccinelli, Francesco Barletta, et al.
Marine Drugs|March 24, 2022
Study of Structure-Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer AgentsMaxim E Zhidkov, Moritz Kaune, Alexey V Kantemirov, et al.
European Urology Open Science|August 18, 2025
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional CohortAlexander Giesen, Daimantas Milonas, Annouschka Laenen, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
International Journal of Cancer|February 14, 2014
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerMartina Kluth, Silvia Harasimowicz, Lia Burkhardt, et al.
International Urology and Nephrology|February 22, 2023
Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalitiesCristina Cano Garcia, Mattia Luca Piccinelli, Stefano Tappero, et al.
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
Pageof 85